Patients With Psoriasis May Benefit From Long-term Treatment With Tildrakizumab

April 15th 2021, 5:37pm


Ilumya (tildrakizumab) was shown to be safe and effective in controlling moderate to severe psoriasis for adults through 5 years of treatment in a recent study.

Study Shows Higher Incidence of Psoriasis in Patients With PCOS

June 30th 2020, 8:31pm


A Taiwanese study revealed that attributes associated with polycystic ovary syndrome (PCOS) may increase the risks of those patients developing psoriasis as well.

Certain Personality Traits in Patients With Psoriasis May Explain Social Anxiety

June 30th 2020, 2:42am


A study analyzing patients with psoriasis revealed that personality traits may have a greater impact on the development of social anxiety than disease severity.

Patient Survey Shows Impact of Psoriatic Arthritis Varies Globally

June 20th 2020, 8:22pm


The impact of psoriatic arthritis on quality of life can vary depending on geographic location and culture, according to a global patient survey.

Treatment With TNF Inhibitors Does Not Reduce Risk of Developing Psoriatic Arthritis After Psoriasis

June 19th 2020, 11:01pm


In 90% of patients, psoriasis precedes psoriatic arthritis by an average of 7 years, providing a window of opportunity for early intervention and possible prevention of psoriatic arthritis.

Immunosuppressive Psoriatic Drugs Don't Increase Risks for COVID-19 Complications

June 13th 2020, 2:00pm


Authors of an opinion piece concluded that not only are immunosuppressed patients with psoriasis not at an increased risk of developing serious complications related to coronavirus disease 2019 (COVID-19), their medications may help mitigate potential issues.

What Is the Impact of Psoriasis on Patients' Mental Health?

June 12th 2020, 1:06am


Patients with psoriasis often have other physical diseases, and these somatic comorbidities can have a bigger effect on the patient’s mental health than the skin symptoms from their psoriasis, according to a study published in JAMA Dermatology.

Real-World Study Examines Treatment Patterns of 2 Biologics for Psoriasis

June 5th 2020, 9:57pm


The study looked at patients taking ixekizumab or adalimumab.

Global Burden of Psoriasis Has Risen for 3 Decades

June 3rd 2020, 5:00pm


A global epidemiological study on psoriasis has found that the prevalence, incidence, and burden of suffering caused by the disease has risen over the last 3 decades.

Examining the Prevalence of Obesity and Depression Among Patients With Psoriasis on Biologics

May 30th 2020, 7:00pm


Use of biologics to treat psoriasis may impact prevalence of comorbidities like depression and obesity, according to an abstract presented at the Virtual 2020 International Society for Pharmacoeconomics and Outcomes Research meeting.